Literature DB >> 17300291

Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents.

B De Smet1, T Thijs, T L Peeters, I Depoortere.   

Abstract

Obestatin has recently been discovered in the rat stomach. It is encoded by the ghrelin gene and has been claimed to be a functional opponent of ghrelin and to be the natural ligand of the GPR39 receptor. The latter could not be confirmed by Holst et al. (Endocrinology, 2006). Yet, in GPR39 knockout mice, gastric emptying is accelerated. We verified the effects of obestatin on gastric emptying and intestinal contractility in rodents. Gastric emptying was measured with the (14)C octanoic breath test in mice. In vitro, the effect of obestatin was studied on electrically stimulated and non-stimulated strips from the fundus and small intestine of mice and rats. Obestatin (60, 125, 250 nmol kg(-1)) did not affect gastric emptying parameters (T(half) and T(lag)) and did not inhibit the prokinetic effects of ghrelin. Mouse and rat intestinal and fundic smooth muscle strips did not respond to obestatin either in the absence or in the presence of electrical field stimulation. Obestatin (125 nmol kg(-1)) did not inhibit fasting-induced hyperphagia. Our results suggest that peripheral obestatin is not a satiety signal that plays a role in the regulation of gastric emptying and do not support the concept that obestatin is a physiological opponent of ghrelin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300291     DOI: 10.1111/j.1365-2982.2006.00883.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  20 in total

Review 1.  GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions.

Authors:  Petra Popovics; Alan J Stewart
Journal:  Cell Mol Life Sci       Date:  2010-09-02       Impact factor: 9.261

2.  Circulating obestatin levels in normal and Type 2 diabetic subjects.

Authors:  D H St-Pierre; F Settanni; I Olivetti; E Gramaglia; M Tomelini; R Granata; F Prodam; A Benso; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

3.  The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice.

Authors:  Eva Szentirmai; Levente Kapás; Yuxiang Sun; Roy G Smith; James M Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

4.  Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.

Authors:  Paweł A Kołodziejski; Ewa Pruszyńska-Oszmałek; Mathias Z Strowski; Krzysztof W Nowak
Journal:  Endocrine       Date:  2017-05-05       Impact factor: 3.633

5.  Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice.

Authors:  I Depoortere; T Thijs; D Moechars; B De Smet; L Ver Donck; T L Peeters
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

6.  Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents.

Authors:  Peter Kobelt; Anna-Sophia Wisser; Andreas Stengel; Miriam Goebel; Norbert Bannert; Guillaume Gourcerol; Tobias Inhoff; Steffen Noetzel; Bertram Wiedenmann; Burghard F Klapp; Yvette Taché; Hubert Mönnikes
Journal:  Peptides       Date:  2008-02-07       Impact factor: 3.750

7.  Ghrelin, des-acyl ghrelin, and obestatin: regulatory roles on the gastrointestinal motility.

Authors:  Mineko Fujimiya; Akihiro Asakawa; Koji Ataka; Chih-Yen Chen; Ikuo Kato; Akio Inui
Journal:  Int J Pept       Date:  2010-03-15

8.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

Review 9.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

10.  Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying.

Authors:  Igor A Harsch; Corinna Koebnick; Atingwa M Tasi; Eckhart Georg Hahn; Peter C Konturek
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.